FDX1 had a relatively high expression in the liver among various normal tissues; however, its expression in liver cancers cannot be detected, suggesting a possible downregulation of the gene during the development of HCC (Supplementary Figures S1A, B). The gene discussed is FDX1; the disease is hepatocellular carcinoma.